The Registry of Toxic Effects of Chemical Substances
p - Benzoquinone |
UPDATE: February 2005 | MW: 108.10 | MF: C6H4O2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA adduct
|
human
bone marrow
|
100 µmol/L
|
CRNGDP 12,1181,1991
|
DNA damage
|
human
mammary gland
|
1 µmol/L/72 hour
|
TOXID9 72,204,2003
|
DNA damage
|
mouse
lymphocyte
|
4 µmol/L
|
PAACA3 27,81,1986
|
DNA inhibition
|
mouse
lymphocyte
|
5 µmol/L
|
MOPMA3 28,560,1985
|
mutation in microorganisms
|
Salmonella typhimurium
|
8 mg/plate (+enzymatic activation step)
|
MUREAV 81,11,1981
|
micronucleus test
|
hamster
lung
|
6,700 µmol/L
|
EVHPAZ 82,81,1989
|
micronucleus test
|
oral | mouse
20 mg/kg
|
MUREAV 208,61,1988
|
micronucleus test
|
mouse
embryo
|
50 µmol/L
|
EMMUEG 19(Suppl 20),21,1992
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
2,100 nmol/L
|
MUTAEX 3,193,1988
|
morphological transform
|
mouse
embryo
|
400 µg/L
|
CRNGDP 16,477,1995
|
other mutation test systems
|
human
lymphocyte
|
5 µmol/L
|
CNREA8 45,2471,1985
|
other mutation test systems
|
mouse
lymphocyte
|
10 µmol/L
|
TOLED5 29,161,1985
|
other mutation test systems
|
mouse
other cell types
|
6 µmol/L
|
CBTOE2 2,231,1986
|
other mutation test systems
|
rabbit
bone marrow
|
2 µmol/L
|
AJIMD8 7,485,1985
|
sister chromatid exchange
|
human
lymphocyte
|
5 µmol/L
|
CNREA8 45,2471,1985
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | mouse
lowest published toxic dose: 800 mg/kg/29 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors
PIATA8 16,309,1940
|
skin | mouse
toxic dose : 6,326 mg/kg/43 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors
GANNA2 39,56,1948
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 8,500 µg/kg
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Behavioral: Muscle contraction or spasticity Lung, Thorax, or Respiration: Cyanosis
BCPCA6 12,885,1963
|
intraperitoneal | rat
lethal dose (50 percent kill): 30 mg/kg
|
N/R
|
PHBUA9 3,337,1955
|
intravenous | rat
lethal dose (50 percent kill): 25 mg/kg
|
N/R
|
FEPRA7 8,348,1949
|
oral | mouse
lethal dose (50 percent kill): 25 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Tremor Skin and Appendages: Other: Hair
NTIS** OTS0571885
|
oral | mouse
lowest published toxic dose: 20 mg/kg/12 hour
|
Blood: Changes in bone marrow not included in above
|
MUREAV 208,61,1988
|
oral | rat
lethal dose (50 percent kill): 130 mg/kg
|
N/R
|
FEPRA7 8,348,1949
|
subcutaneous | mammal (species unspecified)
lethal dose (50 percent kill): 296 mg/kg
|
N/R
|
85GMAT -,25,1982
|
subcutaneous | mouse
lethal dose (50 percent kill): 93,800 µg/kg
|
N/R
|
ZGIMAL 2,333,1947
|
unreported route | rat
lethal dose (50 percent kill): 5,600 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
RPTOAN 41,146,1978
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.1 ppm
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 15,255,1977
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 71,1245,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 15,255,1977
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 71,1245,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMEMDT 71,1245,1999
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,99,2004
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,53,2003
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.1 ppm (0.4 mg/m3)
|
DTLVS* 3,221,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 0.1 ppm (0.4 mg/m3)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 0.1 ppm (0.4 mg/m3)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 0.1 ppm (0.4 mg/m3)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 0.1 ppm (0.4 mg/m3)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 0.1 ppm (0.4 mg/m3), JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.1 ppm (0.4 mg/m3), JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 0.1 ppm (0.4 mg/m3), JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.1 ppm (0.44 mg/m3), JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.1 ppm (0.4 mg/m3), JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.1 ppm (0.4 mg/m3), short term exposure limit 0.3 ppm, Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.1 ppm (0.4 mg/m3), VLE 0.3 ppm (1.5 mg/m3), JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 0.1 ppm (0.4 mg/m3), JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.4 mg/m3, 2003
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 5 ppm (15 mg/m3), JAN1993
|
Occupational Exposure Limit - POLAND
|
time-weighted average 0.1 mg/m3, short term exposure limit 0.4 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.05 mg/m3, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 0.1 ppm (0.4 mg/m3), KTV 0.3 ppm (1.3 mg/m3), JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.1 ppm (0.4 mg/m3), KZG- week 0.2 ppm (0.8 mg/m3), JAN1999
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 0.1 ppm (0.4 mg/m3), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.1 ppm (0.45 mg/m3), short term exposure limit 0.3 ppm (1.3 mg/m3), SEP2000
|
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
time-weighted average 0.1 ppm |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO QUINONE-air
|
10 hour time-weighted average 0.1 ppm
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 66950; | Number of Industries 3; Total Number of Facilities 145; Number of Occupations 6; Total Number of Employees Exposed 3,292
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 66950; |
Number of Industries 17; Total Number of Facilities 1,228; Number of Occupations 18; Total Number of Employees Exposed 15,511; Total Number of Female Employees Exposed 1,274 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE
|
FEREAC 47,26992,82
|
Used as an industrial chemical, chemical intermediate and laboratory reagent
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9079;8EHQ-0892-9083
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85GMAT
|
"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F.,
et al., Moscow, Centre of International Projects, GKNT, 1982
|
AJIMD8
|
American Journal of Industrial Medicine. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.1- 1980-
|
BCPCA6
|
Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1958-
|
CBTOE2
|
Cell Biology and Toxicology. (Princeton Scientific Pub., Inc., 301 N. Harrison St., CN 5279,
Princeton, NJ 08540) V.1- 1984-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FEPRA7
|
Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda,
MD) V.1-46, 1942-87.
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GANNA2
|
Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher
information, see JJCREP.
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
MOPMA3
|
Molecular Pharmacology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)
V.1- 1965-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PAACA3
|
Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston
St., Baltimore, MD 21202) V.1- 1954-
|
PHBUA9
|
Pharmaceutical Bulletin. (Tokyo, Japan) V.1-5, 1953-57. For publisher information, see
CPBTAL.
|
PIATA8
|
Proceedings of the Imperial Academy of Tokyo. (Tokyo, Japan) V.1-21, 1912-45. For publisher
information, see PJACAW.
|
RPTOAN
|
Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed
Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
ZGIMAL
|
Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete. (Buchexport, Postfach 160,
Leipzig DDR-7010, Ger. Dem. Rep.) V.1- 1946-
|
|